(19) Supplemental Guarantor Condensed Consolidating Financial Statements (Unaudited)

The Company’s Senior Notes issued in August 2012 are fully and unconditionally and jointly and severally guaranteed by Hologic, Inc. (“Parent/Issuer”) and each of its domestic subsidiaries. The following represents the supplemental condensed financial information of Hologic, Inc. and its guarantor and non-guarantor subsidiaries, as of March 30, 2013 and September 29, 2012 and for the three and six months ended March 30, 2013 and March 24, 2012.

SUPPLEMENTAL CONDENSED CONSOLIDATING BALANCE SHEET

March 30, 2013


	Parent/Issuer		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations			Consolidated
ASSETS
Current assets:
Cash and cash equivalents	$	188,551	$	455,672	$	100,773	$	—		$	744,996
Restricted cash		—		—		7,179		—			7,179
Accounts receivable, net		98,705		179,059		123,458		79			401,301
Inventories		82,179		173,552		64,287		(20	)		319,998
Deferred income tax assets		—		15,615		626		(16,241	)		—
Prepaid income taxes		55,334		38,691		—		(7,480	)		86,545
Prepaid expenses and other current assets		19,722		13,825		13,059		—			46,606
Intercompany receivables		—		2,228,533		50,594		(2,279,127	)		—
Other current assets – assets held-for-sale		—		—		623		—			623

Total current assets		444,491		3,104,947		360,599		(2,302,789	)		1,607,248

Property and equipment, net		29,369		371,986		101,284		—			502,639
Intangible assets, net		22,815		3,962,339		107,962		—			4,093,116
Goodwill		281,860		3,519,856		139,593		—			3,941,309
Other assets		114,838		48,679		1,365		12			164,894
Investment in subsidiaries		9,847,845		100,772		2,296		(9,950,913	)		—

Total assets	$	10,741,218	$	11,108,579	$	713,099	$	(12,253,690	)	$	10,309,206


LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	28,494	$	37,621	$	9,494	$	—		$	75,609
Accrued expenses		207,071		71,048		43,867		(7,746	)		314,240
Deferred revenue		86,624		9,502		29,540		—			125,666
Current portion of long-term debt		453,677		—		—		—			453,677
Deferred income tax liabilities		57,340		—		—		(16,241	)		41,099
Intercompany payables		2,198,427		—		88,405		(2,286,832	)		—
Other current liabilities – assets held-for-sale		—		—		15		—			15

Total current liabilities		3,031,633		118,171		171,321		(2,310,819	)		1,010,306

Long-term debt, net of current portion		4,551,019		—		—		—			4,551,019
Deferred income tax liabilities		72,842		1,499,591		10,541		—			1,582,974
Deferred service obligations – long-term		9,585		2,551		12,326		(2,191	)		22,271
Other long-term liabilities		85,576		33,706		32,790		—			152,072

Total liabilities		7,750,655		1,654,019		226,978		(2,313,010	)		7,318,642
Total stockholders’ equity		2,990,563		9,454,560		486,121		(9,940,680	)		2,990,564

Total liabilities and stockholders’ equity	$	10,741,218	$	11,108,579	$	713,099	$	(12,253,690	)	$	10,309,206

SUPPLEMENTAL CONDENSED CONSOLIDATING BALANCE SHEET

September 29, 2012


	Parent/Issuer		Guarantor Subsidiaries		Non-Guarantor Subsidiaries		Eliminations			Consolidated
ASSETS
Current assets:
Cash and cash equivalents	$	210,028	$	269,416	$	80,986	$	—		$	560,430
Restricted cash		—		—		5,696		—			5,696
Accounts receivable, net		101,538		192,349		115,522		(76	)		409,333
Inventories		74,500		223,043		70,180		(532	)		367,191
Deferred income tax assets		13,578		—		617		(2,480	)		11,715
Prepaid income taxes		20,805		48,429		611		—			69,845
Prepaid expenses and other current assets		18,817		12,816		12,668		—			44,301
Intercompany receivables		—		2,094,017		55,761		(2,149,778	)		—
Other current assets – assets held-for-sale		—		67,878		26,625		—			94,503

Total current assets		439,266		2,907,948		368,666		(2,152,866	)		1,563,014

Property and equipment, net		26,928		379,702		101,368		—			507,998
Intangible assets, net		24,034		4,162,930		114,286		—			4,301,250
Goodwill		279,956		3,522,474		140,349		—			3,942,779
Other assets		112,339		49,036		2,406		(1,714	)		162,067
Investments in subsidiaries		9,782,940		101,615		2,296		(9,886,851	)		—

Total assets	$	10,665,463	$	11,123,705	$	729,371	$	(12,041,431	)	$	10,477,108


LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	29,847	$	43,339	$	14,037	$	—		$	87,223
Accrued expenses		238,387		86,566		50,052		(2,624	)		372,381
Deferred revenue		92,234		10,307		27,147		—			129,688
Current portion of long-term debt		64,435		—		—		—			64,435
Intercompany payables		2,085,339		6,655		66,335		(2,158,329	)		—
Other current liabilities – assets held-for-sale		—		5,520		2,102		—			7,622

Total current liabilities		2,510,242		152,387		159,673		(2,160,953	)		661,349

Long-term debt, net of current portion		4,971,179		—		—		—			4,971,179
Deferred income tax liabilities		180,916		1,581,833		8,836		—			1,771,585
Deferred service obligations – long-term		7,536		1,160		7,601		(2,583	)		13,714
Other long-term liabilities		34,559		30,587		34,504		(1,400	)		98,250

Total liabilities		7,704,432		1,765,967		210,614		(2,164,936	)		7,516,077
Total stockholders’ equity		2,961,031		9,357,738		518,757		(9,876,495	)		2,961,031

Total liabilities and stockholders’ equity	$	10,665,463	$	11,123,705	$	729,371	$	(12,041,431	)	$	10,477,108

SUPPLEMENTAL CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS

For the Three Months Ended March 30, 2013


	Parent/Issuer			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Eliminations			Consolidated
Revenues:
Product sales	$	100,614		$	398,811		$	121,340		$	(102,751	)	$	518,014
Service and other revenues		81,176			19,422			9,535			(15,484	)		94,649

		181,790			418,233			130,875			(118,235	)		612,663

Costs and expenses:
Cost of product sales		52,488			170,310			88,231			(102,751	)		208,278
Cost of product sales – amortization of intangible assets		1,309			73,374			1,050			—			75,733
Cost of service and other revenues		40,620			15,777			8,413			(15,484	)		49,326
Research and development		7,234			39,973			2,414			—			49,621
Selling and marketing		20,484			45,237			22,893			—			88,614
General and administrative		16,716			38,631			8,886			—			64,233
Amortization of intangible assets		777			26,687			1,203			—			28,667
Contingent consideration – compensation expense		29,388			—			—			—			29,388
Contingent consideration – fair value adjustments		799			—			—			—			799
Restructuring and divestiture net charges		164			10,600			3,092			(1,394	)		12,462

		169,979			420,589			136,182			(119,629	)		607,121

Income (loss) from operations		11,811			(2,356	)		(5,307	)		1,394			5,542
Interest income		99			36			72			—			207
Interest expense		(75,238	)		(309	)		(502	)		—			(76,049	)
Debt extinguishment loss		(3,247	)		—			—			—			(3,247	)
Other (expense) income, net		1,638			(3,073	)		1,247			(13	)		(201	)

(Loss) income before income taxes		(64,937	)		(5,702	)		(4,490	)		1,381			(73,748	)
(Benefit) provision for income taxes		(14,842	)		(8,081	)		279			—			(22,644	)
Equity in earnings (losses) of subsidiaries		(1,009	)		2,459			—			(1,450	)		—

Net (loss) income	$	(51,104	)	$	4,838		$	(4,769	)	$	(69	)	$	(51,104	)

SUPPLEMENTAL CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS

For the Six Months Ended March 30, 2013


	Parent/Issuer			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Eliminations			Consolidated
Revenues:
Product sales	$	198,657		$	778,582		$	254,415		$	(178,438	)	$	1,053,216
Service and other revenues		159,136			40,563			19,407			(28,297	)		190,809

		357,793			819,145			273,822			(206,735	)		1,244,025

Costs and expenses:
Cost of product sales		106,008			334,205			169,996			(178,438	)		431,771
Cost of product sales – amortization of intangible assets		2,615			146,291			2,114			—			151,020
Cost of service and other revenues		78,998			31,368			18,166			(28,297	)		100,235
Research and development		14,652			81,726			4,752			—			101,130
Selling and marketing		41,257			92,602			49,198			—			183,057
General and administrative		32,036			69,647			16,941			—			118,624
Amortization of intangible assets		1,455			53,336			2,402			—			57,193
Contingent consideration – compensation expense		58,874			—			—			—			58,874
Contingent consideration – fair value adjustments		10,839			—			—			—			10,839
Gain on sale of intellectual property, net		—			(53,884	)		—			—			(53,884	)
Restructuring and divestiture net charges		385			13,886			3,518			(1,394	)		16,395


		347,119			769,177			267,087			(208,129	)		1,175,254

Income from operations		10,674			49,968			6,735			1,394			68,771
Interest income		230			78			159			—			467
Interest expense		(146,492	)		(623	)		(1,015	)		—			(148,130	)
Debt extinguishment loss		(3,247	)		—			—			—			(3,247	)
Other income (expense), net		1,757			(7,119	)		6,427			(27	)		1,038

(Loss) income before income taxes		(137,078	)		42,304			12,306			1,367			(81,101	)
(Benefit) provision for income taxes		(26,589	)		(11,195	)		4,669			—			(33,115	)
Equity in earnings (losses) of subsidiaries		62,503			13,393			—			(75,896	)		—

Net (loss) income	$	(47,986	)	$	66,892		$	7,637		$	(74,529	)	$	(47,986	)

SUPPLEMENTAL CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS

For the Three Months Ended March 24, 2012


	Parent/Issuer			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Eliminations			Consolidated
Revenues:
Product sales	$	105,485		$	248,435		$	103,727		$	(69,562	)	$	388,085
Service and other revenues		74,836			15,122			7,105			(13,983	)		83,080

		180,321			263,557			110,832			(83,545	)		471,165

Costs and expenses:
Cost of product sales		53,947			94,789			75,249			(69,562	)		154,423
Cost of product sales – amortization of intangible assets		1,304			42,911			126			—			44,341
Cost of service and other revenues		38,474			14,487			7,313			(13,983	)		46,291
Research and development		6,553			19,385			3,359			—			29,297
Selling and marketing		15,686			42,509			20,344			—			78,539
General and administrative		12,110			22,087			7,646			—			41,843
Amortization of intangible assets		677			13,860			2,092			—			16,629
Contingent consideration – compensation expense		18,121			—			—			—			18,121
Contingent consideration – fair value adjustments		43,188			—			—			—			43,188
Gain on sale of intellectual property, net		—			(12,424	)		—			—			(12,424	)
Restructuring and divestiture net charges		—			196			587			—			783

		190,060			237,800			116,716			(83,545	)		461,031

Income (loss) from operations		(9,739	)		25,757			(5,884	)		—			10,134
Interest income		463			31			96			—			590
Interest expense		(27,662	)		(360	)		(490	)		—			(28,512	)
Debt extinguishment loss		(42,347	)		—			—			—			(42,347	)
Other income, net		1,418			48			61			—			1,527

(Loss) income before income taxes		(77,867	)		25,476			(6,217	)		—			(58,608	)
(Benefit) provision for income taxes		(31,518	)		15,067			(1,884	)		—			(18,335	)
Equity in earnings (losses) of subsidiaries		6,076			2,403			—			(8,479	)		—

Net (loss) income	$	(40,273	)	$	12,812		$	(4,333	)	$	(8,479	)	$	(40,273	)

SUPPLEMENTAL CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS

For the Six Months Ended March 24, 2012


	Parent/Issuer			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Eliminations			Consolidated
Revenues:
Product sales	$	211,246		$	498,883		$	206,261		$	(136,209	)	$	780,181
Service and other revenues		148,264			29,648			14,367			(28,584	)		163,695

		359,510			528,531			220,628			(164,793	)		943,876

Costs and expenses:
Cost of product sales		107,637			175,510			139,429			(136,209	)		286,367
Cost of product sales – amortization of intangible assets		2,609			85,821			2,082			—			90,512
Cost of service and other revenues		77,709			28,217			14,175			(28,584	)		91,517
Research and development		13,797			37,515			6,327			—			57,639
Selling and marketing		32,183			84,755			39,061			—			155,999
General and administrative		25,130			46,277			16,931			—			88,338
Amortization of intangible assets		1,354			27,719			2,398			—			31,471
Contingent consideration – compensation expense		28,562			—			—			—			28,562
Contingent consideration – fair value adjustments		48,310			—			—			—			48,310
Gain on sale of intellectual property, net		—			(12,424	)		—			—			(12,424	)
Non-recurring charges		—			—			(91	)		—			(91	)
Restructuring and divestiture net charges		—			196			587			—			783

		337,291			473,586			220,899			(164,793	)		866,983

Income (loss) from operations		22,219			54,945			(271	)		—			76,893
Interest income		1,041			77			134			—			1,252
Interest expense		(56,371	)		(687	)		(963	)		—			(58,021	)
Debt extinguishment loss		(42,347	)		—			—			—			(42,347	)
Other income, net		2,882			69			568			—			3,519

(Loss) income before income taxes		(72,576	)		54,404			(532	)		—			(18,704	)
Provision (benefit) for income taxes		(25,309	)		23,638			2,428			—			757
Equity in earnings (losses) of subsidiaries		27,806			5,793			557			(34,156	)		—

Net (loss) income	$	(19,461	)	$	36,559		$	(2,403	)	$	(34,156	)	$	(19,461	)

SUPPLEMENTAL CONDENSED CONSOLIDATING STATEMENTS OF COMPREHENSIVE (LOSS) INCOME

For the Three Months Ended March 30, 2013


	Parent/Issuer			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Eliminations			Consolidated
Net (loss) income	$	(51,104	)	$	4,838		$	(4,769	)	$	(69	)	$	(51,104	)
Change in cumulative translation adjustment		—			(341	)		(7,947	)		—			(8,288	)
Unrealized loss on available-for-sale securities		—			2,687			—			—			2,687

Comprehensive (loss) income	$	(51,104	)	$	7,184		$	(12,716	)	$	(69	)	$	(56,705	)

For the Six Months Ended March 30, 2013


	Parent/Issuer			Guarantor Subsidiaries		Non-Guarantor Subsidiaries			Eliminations			Consolidated
Net (loss) income	$	(47,986	)	$	66,892	$	7,637		$	(74,529	)	$	(47,986	)
Change in cumulative translation adjustment		—			236		(6,555	)		—			(6,319	)
Unrealized loss on available-for-sale securities		—			2,130		—			—			2,130

Comprehensive (loss) income	$	(47,986	)	$	69,258	$	1,082		$	(74,529	)	$	(52,175	)

For the Three Months Ended March 24, 2012


	Parent/Issuer			Guarantor Subsidiaries		Non-Guarantor Subsidiaries			Eliminations			Consolidated
Net (loss) income	$	(40,273	)	$	12,812	$	(4,333	)	$	(8,479	)	$	(40,273	)
Change in cumulative translation adjustment		—			85		4,949			—			5,034

Comprehensive (loss) income	$	(40,273	)	$	12,897	$	616		$	(8,479	)	$	(35,239	)

For the Six Months Ended March 24, 2012


	Parent/Issuer			Guarantor Subsidiaries		Non-Guarantor Subsidiaries			Eliminations			Consolidated
Net (loss) income	$	(19,461	)	$	36,559	$	(2,403	)	$	(34,156	)	$	(19,461	)
Change in cumulative translation adjustment		—			44		4,632			—			4,676

Comprehensive (loss) income	$	(19,461	)	$	36,603	$	2,229		$	(34,156	)	$	(14,785	)

CONSOLIDATING STATEMENT OF CASH FLOWS

For the Six Months Ended March 30, 2013


	Parent/Issuer			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Eliminations		Consolidated
OPERATING ACTIVITIES
Net cash provided by operating activities	$	65,009		$	72,387		$	32,132		$	—	$	169,528

INVESTING ACTIVITIES
Acquisition of a business		(3,698	)		—			(220	)		—		(3,918	)
Payment of additional acquisition consideration		(16,808	)		—			—			—		(16,808	)
Proceeds from sale of business, net of cash transferred		—			84,762			1,488			—		86,250
Purchase of property and equipment		(6,397	)		(14,335	)		(5,156	)		—		(25,888	)
Increase in equipment under customer usage agreements		(335	)		(13,031	)		(7,589	)		—		(20,955	)
Purchase of insurance contracts		(4,000	)		—			—			—		(4,000	)
Proceeds from sale of intellectual property		—			60,000			—			—		60,000
Purchase of cost-method investments		(3,400	)		(225	)		—			—		(3,625	)
Increase in other assets		(1,984	)		(1,520	)		(1,447	)		—		(4,951	)

Net cash provided by (used in) investing activities		(36,622	)		115,651			(12,924	)		—		66,105

FINANCING ACTIVITIES
Repayment of long-term debt		(32,500	)		—			—			—		(32,500	)
Payment of debt issuance cost		(7,019	)										(7,019	)
Payment of contingent consideration		(42,433	)		—			—			—		(42,433	)
Net proceeds from issuance of common stock pursuant to employee stock plans		37,623			—			—			—		37,623
Excess tax benefit related to equity awards		4,437			—			—			—		4,437
Payment of employee restricted stock minimum tax withholdings		(9,972	)		—			—			—		(9,972	)

Net cash used in financing activities		(49,864	)		—			—			—		(49,864	)
Effect of exchange rate changes on cash and cash equivalents		—			(1,782	)		579			—		(1,203	)

Net increase (decrease) in cash and cash equivalents		(21,477	)		186,256			19,787			—		184,566
Cash and cash equivalents, beginning of period		210,028			269,416			80,986			—		560,430

Cash and cash equivalents, end of period	$	188,551		$	455,672		$	100,773		$	—	$	744,996

CONSOLIDATING STATEMENT OF CASH FLOWS

For the Six Months Ended March 24, 2012


	Parent/Issuer			Guarantor Subsidiaries			Non-Guarantor Subsidiaries			Eliminations		Consolidated
OPERATING ACTIVITIES
Net cash provided by operating activities	$	199,520		$	2,888		$	10,427		$	—	$	212,835

INVESTING ACTIVITIES
Payment of additional acquisition consideration		(9,784	)		—			—			—		(9,784	)
Proceeds from sale of intellectual property		—			12,500			—			—		12,500
Purchase of property and equipment		(7,034	)		(3,533	)		(3,665	)		—		(14,232	)
Increase in equipment under customer usage agreements		—			(11,797	)		(7,528	)		—		(19,325	)
Purchase of cost-method investment		—			(250	)		—			—		(250	)
Increase in other assets		—			—			1			—		1

Net cash used in investing activities		(16,818	)		(3,080	)		(11,192	)		—		(31,090	)

FINANCING ACTIVITIES
Payment of contingent consideration		(51,680	)		—			—			—		(51,680	)
Payment of debt issuance costs		(5,822	)		—			—			—		(5,822	)
Net proceeds from issuance of common stock pursuant to employee stock plans		20,389			—			—			—		20,389
Excess tax benefit related to equity awards		2,683			—			—			—		2,683
Payment of employee restricted stock minimum tax withholdings		(5,696	)		—			—			—		(5,696	)

Net cash used in financing activities		(40,126	)		—			—			—		(40,126	)
Effect of exchange rate changes on cash and cash equivalents		—			192			418			—		610

Net increase (decrease) in cash and cash equivalents		142,576			—			(347	)		—		142,229
Cash and cash equivalents, beginning of period		644,697			—			67,635			—		712,332

Cash and cash equivalents, end of period	$	787,273		$	—		$	67,288		$	—	$	854,561